Search results
Author(s):
Diarmaid Cadogan
,
Marwa Daghem
,
Mostafa Snosi
,
et al
Added:
10 months ago
Author(s):
Timothy Glenie
,
Peter Ruygrok
Added:
3 years ago
Abstract
As the treatment of acute myocardial infarction has evolved from conservative management to thrombolysis and, in more recent times, primary angioplasty, the incidence of ventricular rupture, in particular post-infarction ventricular septal defect (VSD), appears to have fallen. In this article we discuss the clinical presentation and investigation of post-infarction VSD, the natural…
View more
Patrick A Calvert
Research Area(s) / Expertise:
Author
Author(s):
Jean-François Paul
Added:
3 years ago
In the clinical management of patients with complex congenital heart disease (CHD), accurate 3D evaluation of their morphological conditions is critical. 3D imaging should demonstrate the shape and spatial relation of great arteries, proximal branch pulmonary arteries and anomalous pulmonary venous or systemic connections, and eventually coronary artery course. 3D information on extra-cardiac…
View more
Annular Rupture During TAVI
Author(s):
JJ Coughlan
,
Thomas J Kiernan
,
Darren Mylotte
,
et al
Added:
3 years ago
Article
Author(s):
Colm Hanratty
,
Simon J Walsh
Added:
3 years ago
Chronic total occlusions (CTO) are a common finding at angiography in patients with coronary artery disease (CAD); they are present in ~20% of cases at angiography (excluding those with acute MI or prior coronary artery bypass graft (CABG).1 Data from the same Canadian registry showed that only 10% of CTO patients had had a percutaneous coronary intervention (PCI) attempted to treat CTO, with…
View more
Author(s):
Satinder K Sandhu
Added:
3 years ago
Over the last three decades numerous transcatheter therapies for the treatment of congenital heart disease (CHD) have been developed.
Interatrial Septal Defect
Balloon atrial septostomy has been performed in patients with transposition physiology and in patients where egress of blood is needed from the left or the right atrium and in adults with pulmonary vascular disease where the creation of…
View more
Author(s):
Robert J Applegate
Added:
3 years ago
Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction
Achieving reperfusion in a timely fashion in patients with ST-elevation myocardial infarction (STEMI) has been established as an effective and life-saving treatment.1–4 This has usually been measured as door-to-balloon time with an established goal of 90 minutes as the time within which reperfusion should be achieved…
View more
Author(s):
Amar Krishnaswamy
,
Emin Murat Tuzcu
,
Samir R Kapadia
Added:
3 years ago
Among patients undergoing surgical valve replacement, 1–5 % of patients with an aortic valve replacement (AVR) and 2–12 % with a mitral valve replacement (MVR) may develop paravalvular regurgitation or ‘leak’ (PVL).1–3 In the era of transcatheter aortic valve replacement (TAVR) with first-generation balloon expandable valves, up to 17 % of patients may be left with moderate or severe PVL, also…
View more
Author(s):
Aman Ali
,
Timothy A Sanborn
Added:
3 years ago
Cardiogenic shock (CS) remains the leading cause of death among patients hospitalised for acute myocardial infarction (AMI), with mortality rates of approximately 50%.1 Even with the benefit of thrombolytic therapy and intra-aortic balloon pumps (IABPs), the in-hospital mortality rate of patients with CS from AMI was only lowered from 63 to 47% according to a report from the SHould we emergently…
View more